健保藥品的HTA評估報告
- 181 TRELEGY ELLIPTA 92/55/22 mcg Inhalation Powder
- 182 Herceptin Solution for Injection
- 183 俐速美注射劑(Lyxumia solution for injection,10mcg/0.2ml、20mcg/0.2ml)
- 184 樂衛瑪膠囊(Lenvima®)
- 185 Aubagio F.C. Tablets 14mg
- 186 普澤力®膜衣錠(Prezcobix® Film-Coated Tablets)
- 187 安得能微脂體注射劑5毫克/毫升(Onivyde)
- 188 達癬治注射劑(Taltz®)
- 189 愛滅炎®膜衣錠4毫克/愛滅炎®膜衣錠2毫克(Olumiant 2mg、4mg film-coated Tablets)
- 190 艾百樂(Maviret Film-Coated Tablets 100mg/40mg)
- 191 Blincyto® for Injection
- 192 Trokendi XR extended-release capsules 25mg、50mg、100mg、200mg
- 193 抑凝安膜衣錠3.75及5毫克(Efient F.C.Tablets 3.75mg/5mg)
- 194 TBSF Human Immunoglobulin for Intravenous Use
- 195 TBSF Human Immunoglobulin for Intravenous Use(更新版)
- 196 舒肺樂凍晶注射劑(Nucala Powder for Solution for Injection)
- 197 舒肺樂凍晶注射劑(Nucala Powder for Solution for Injection)
- 198 泰福德膠囊(Tecfidera 120mg 及240mg)
- 199 嘔可舒膠囊(Akynzeo)
- 200 Glyxambi Film Coated Tablets 25/5mg 及10/5mg